WebDisclosure WebDisclosure
Basculer en Français
10909 Companies
237876 Keywords
166756 Articles
127766 Press releases
Headlines Articles Press releases CAGE Bio Inc. Remove
  1. Home
  2. Companies
  3. CAGE Bio Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/09/2025 at 21:05, 1 year 7 months ago

    CAGE Bio Launches Phase 2b Trial for Atopic Dermatitis Treatment CGB-500

    Phase 2B Trial Atopic Dermatitis CAGE Bio CGB-500 Ionic Liquid Technology
  • BRIEF

    published on 01/09/2025 at 21:05, 1 year 7 months ago

    CAGE Bio lance un essai de phase 2b pour le traitement de la dermatite atopique CGB-500

    CGB-500 Biographie De CAGE Essai De Phase 2b Dermatite Atopique Technologie Des Liquides Ioniques
  • PRESS RELEASE

    published on 01/09/2025 at 21:00, 1 year 7 months ago

    CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis

    CAGE Bio initiates Phase 2b trial for CGB-500, a topical JAK inhibitor ointment for atopic dermatitis. High efficacy, low side-effects. Improving patient outcomes
    Phase 2B Trial Atopic Dermatitis CAGE Bio CGB-500 Topical Therapy
    Logo of CAGE Bio Inc.
  • PRESS RELEASE

    published on 08/03/2023 at 16:45, 3 years ago

    CAGE Bio Announces Positive Topline Results From its Double-Blind Phase 2 Study Evaluating an Ionic Liquid formulation of 1% Tofacitinib In Patients with Atopic Dermatitis

    Logo of CAGE Bio Inc.
Accesswire
  • Published on 09/01/2026 at 16:10, 47 minutes ago

    Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development

  • Published on 09/01/2026 at 15:40, 1 hour 17 minutes ago

    Norsemont Provides Choquelimpie Drilling Update

  • Published on 09/01/2026 at 15:30, 1 hour 27 minutes ago

    Caldwell Launches Global Financial Institutions Group Practice

  • Published on 09/01/2026 at 14:31, 2 hours 26 minutes ago

    First Breach Expands Ammunition Manufacturing Capacity with Installation of New Loading and Inspection Equipment

  • Published on 09/01/2026 at 14:00, 2 hours 57 minutes ago

    Horizon Aircraft Advances All-Weather Certification Path with the Start of Ice Protection Technology Testing

View all ACCESSWIRE
EQS Group
  • Published on 09/01/2026 at 16:16, 41 minutes ago

    Genel Energy PLC: Statement regarding offer for Capricorn Energy plc (“Capricorn”)

  • Published on 09/01/2026 at 16:00, 57 minutes ago

    Shares Admitted to Trading and Total Voting Rights

  • Published on 09/01/2026 at 15:40, 1 hour 17 minutes ago

    EQS-Adhoc: CANCOM SE: CANCOM decides on share buyback

  • Published on 09/01/2026 at 15:35, 1 hour 22 minutes ago

    Demande stable de voitures électriques dans un marché tendu

  • Published on 09/01/2026 at 15:05, 1 hour 52 minutes ago

    TUMI REVEALS FALL/WINTER 2026 COLLECTION WITH CAMPAIGN FOLLOWING LANDO NORRIS' PATH TO NEW PEAKS

View all EQS
Les Echos
  • Published on 08/31/2026 at 18:00, 22 hours 57 minutes ago

    MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2025/2026

  • Published on 08/31/2026 at 17:45, 23 hours 12 minutes ago

    Disclosure of transactions in own shares from August 24 to August 28, 2026

  • Published on 08/31/2026 at 17:45, 23 hours 12 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 24 au 28 août 2026

  • Published on 08/31/2026 at 17:45, 23 hours 12 minutes ago

    Déclaration hebdomadaire de rachat d'actions

  • Published on 08/31/2026 at 17:45, 23 hours 12 minutes ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy